John C. Cheneval
Corporate Officer/Principal at CASTLE BIOSCIENCES, INC.
Profile
John C.
Cheneval is currently working as the Executive Director-Business Development at Castle Biosciences, Inc. Prior to his current position, he worked as the Vice President-Pharma Partnerships at HTG Molecular Diagnostics, Inc. from 2018 to 2021.
He also served as the Executive Vice President-Sales & Marketing at Akers Biosciences, Inc. In terms of education, Mr. Cheneval completed his undergraduate degree at LSU Medical School and Louisiana State University.
John C. Cheneval active positions
| Companies | Position | Start |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Corporate Officer/Principal | 31/12/2020 |
Former positions of John C. Cheneval
| Companies | Position | End |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Corporate Officer/Principal | 31/12/2020 |
| MYMD PHARMACEUTICALS, INC. | Sales & Marketing | - |
Training of John C. Cheneval
| Louisiana State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| Private companies | 1 |
|---|---|
Akers Biosciences, Inc.
 Akers Biosciences, Inc. Medical SpecialtiesHealth Technology Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- John C. Cheneval
